ARCA biopharma Announces 2022 Financial Results and Provides Corporate Update

February 24, 2023

https://www.globenewswire.com/news-release/2023/02/24/2615557/0/en/ARCA-biopharma-Announces-2022-Financial-Results-and-Provides-Corporate-Update.html

WESTMINSTER, Colo., Feb. 24, 2023 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq:ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today reported 2022 financial results and provided a corporate update.

Read more at globenewswire.com

Related news for (ABIO)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.